Archives

by in
Entry Author Date Location
Exelixis and Onyx Await Their Cancer-Drug Fates 09/18/12 San Francisco
Fearless Football and Biotech Picks For Fall 2012 09/04/12 National
Regulus Therapeutics Files for IPO as ‘Emerging Growth’ Company 08/20/12 San Diego
Kala, ImmunoGen, Boring Biotech, & More Boston Life Sciences News 07/13/12 Boston
Bristol-Myers Buys Amylin for $5.3B, Getting Diabetes Drugs 06/29/12 San Diego
Pfizer Takes on Genzyme With New Gaucher Drug 05/02/12 Boston
Genzyme, Epizyme, & Rib-X Among the Week’s Life Sciences Newsmakers 04/27/12 Boston
Cytokinetics Shows Hint of Effect With Drug for Lou Gehrig’s Disease 04/25/12 San Francisco
New Data on Genzyme MS Drug Shows Improvement in Disability 04/24/12 Boston
What Are the Hottest Targets in Biotech Today? 04/23/12 National
Xconomy Boston’s Top 20 Stories of Q1: Editor’s Picks 04/02/12 Boston
Biotech Can’t Sidestep Cost-Effectiveness Anymore 04/02/12 National
Third Rock’s Mark Levin: ‘Ultra-Super Positive’ on Biotech Innovation 03/29/12 Boston
Option to Buy: The New Face of Biotech Funding? 02/13/12 National
Biotech Is Raising More Cash, But Don’t Be Fooled: Startups are Hurting 01/23/12 National
Report: UCSF Chancellor Proposes Autonomy in State University System 01/20/12 San Francisco
Genzyme, Veracyte Strike Deal to Market Thyroid Cancer Diagnostic 01/20/12 San Francisco
J&J Opens San Diego Biotech Startup Center, Says ‘No Strings Attached’ 01/18/12 San Diego
Sanofi CEO Viehbacher on Stirring Innovation in the Era of R&D Cutbacks 01/17/12 National
The Boston Life Sciences Newsmakers: Civitas, Blend, Forma, & More 01/13/12 Boston
LogMeIn, Safari, Forma, And More Behind the Boston-Area Deals News 01/11/12 Boston
Foundation Medicine and Sanofi Form Cancer Discovery Pact 01/10/12 Boston
Warp Drive Bio Launches With $125M from Third Rock, Greylock, Sanofi 01/10/12 Boston
Alnylam Gets First Hint of Effectiveness for RNAi Cholesterol-Lowering Drug 01/04/12 Boston
Momenta, Baxter Team Up on Biosimilars 12/23/11 Boston
Rib-X Pharma Files for IPO 11/28/11 Boston
Genzyme MS Drug Significantly Reduces Relapse, Disability in Late-Stage Trial 11/14/11 Boston
Verastem, the 15-Month Old Christoph Westphal Venture in Cancer Stem Cells, Seeks IPO 11/03/11 Boston
Medivation, Astellas Prostate Cancer Drug Helps Men Live Longer; Shares Skyrocket 11/03/11 San Francisco
Sanofi Names David Meeker New CEO of Genzyme, Will Report to Viehbacher 10/24/11 Boston
Page 2 of 3 « previous page · next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  5. Announcing Xconomy Napa Summit 2013: New Rules for Growth

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.